Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open-label, Loading and Maintenance Dose Finding Study of GTx-758 in Men With Prostate Cancer

NCT01393119 is registered in ClinicalTrials.gov with GTx as lead sponsor.

NCT NCT01393119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01393119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open-label, Loading and Maintenance Dose Finding Study of GTx-758 in Men With Prostate Cancer
Lead sponsor
GTx
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2011
Completion date
December 31, 2012
Enrollment
77 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer